Cytogenetic biomarkers and genetic polymorphisms

Toxicology Letters

Volumn 149, Issue 1-3, 2004, Pages 309-334

  Norppa, Hannu ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Chromosome aberration; Cytogenetic biomarker; Genotype; Micronucleus; Polymorphism; Sister chromatid exchange

Indexed keywords

ACYLTRANSFERASE; BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE; TOBACCO SMOKE;

ACETYLATION; CANCER RISK; CANCER SCREENING; CHROMOSOME ABERRATION; CONFERENCE PAPER; CYTOGENETICS; DNA REPAIR; FOLATE METABOLISM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTOXICITY; GENOTYPE; HUMAN; LYMPHOCYTE; MICRONUCLEUS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE; SMOKING;

ANIMALS; CYTOGENETIC ANALYSIS; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FOLIC ACID; GENETIC MARKERS; HUMANS; POLYMORPHISM, GENETIC; SMOKING; XENOBIOTICS;

NICOTIANA TABACUM;

EID: 1842766408     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.12.042     Document Type: Conference Paper

References (174)

1. Abdel-Rahman S.Z., El-Zein R.A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 159:2000;63-71.
2. Abdel-Rahman S.Z., El-Zein R., Zwischenberger J.B., Au W.W. Association of the NAT*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. Mutat. Res. 398:1998;43-54.
3. Abdel-Rahman S.Z., Salama S.A., Au W.W., Hamada F.A. Role of polymorphic CYP2E1 and CYP2D6 in NNK-induced chromosome aberrations in cultured human lymphocytes. Pharmacogenetics. 10:2000;239-249.
4. Abdel-Rahman S.Z., Ammenheuser M.M., Ward J.B. Jr. Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis. 22:2001;415-423.
5. Albertini R.J., Anderson D., Douglas G.R., Hagmar L., Hemminki K., Merlo F., Natarajan A.T., Norppa H., Shuker D.E., Tice R., Waters M.D., Aitio A. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat. Res. 463:2000;111-172.
6. Albertini R.J., Šrám R.J., Vacek P.M., Lynch J., Wright M., Nicklas J.A., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward J.B. Jr. Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem. Biol. Interact. 135-136:2001;429-453.
7. Alexandrov K., Cascorbi I., Rojas M., Bouvier G., Kriek B., Bartsch H. CYPlAl and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis. 23:2002;1969-1977.
8. Andreassi M.-G., Botto N., Cocci F., Battaglia D., Antonioli B., Masetti S., Manfredi S., Colombo M.G., Biagini A., Clerico A. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum. Genet. 112:2003;171-177.
9. Au W.W., Sierra-Torres C.H., Cajas-Salazar N., Salama S.A. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ. Health Perspect. 107:1999;501-505.
10. Au W.W., Oh H.Y., Grady J., Salama S.A., Heo M.Y. Useflilness of genetic susceptibility and biomarkers for evaluation of environmental health risk. Environ. Mol. Mut. 37:2001;215-225.
11. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464:2000;65-76.
12. Begemann P., Šrám R.J., Neumann H.O. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3-butadiene. Arch. Toxicol. 74:2001;680-687.
13. Benhamou S., Reinikainen M., Bouchardy C., Dayer P., Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 58:1998;5291-5293.
14. Benhamou S., Lee W.J., Alexandrie A.K., Boffetta P., Bouchardy C., Butkiewicz D., Brockmöller J., Clapper M.L., Daly A., Dolzan V., Ford J., Gaspari L., Haugen A., Hirvonen A., Husgafvel-Pursiainen K., Ingelman-Sundberg M., Kalina I., Kihara M., Kremers P., Le Marchand L., London S.J., Nazar-Stewart V., Onon-Kihara M., Rannug A., Romkes M., Ryberg D., Seidegård J., Shields P., Strange R.C., Stücker I., To-Figueras J., Brennan P., Taioli E. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 23:2002;1343-1350.
15. Bernardini S., Hirvonen A., Pelin K., Norppa H. Induction of sister chromatid exchange by 1,2-epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype. Carcinogenesis. 19:1998;377-380.
16. Bernardini S., Hirvonen A., Järventaus H., Norppa H. Trans-stilbene oxide-induced sister chromatid exchange in cultured human lymphocytes: influence of GSTM1 and GSTT1 genotypes. Mutagenesis. 16:2001;277-281.
17. Bemardini S., Hirvonen A., Järventaus H., Norppa H. Influence of GSTM1 and GSTT1 genotypes on sister chromatid exchange induction by styrene in cultured human lymphocytes. Carcinogenesis. 23:2002;893-897.
18. Binková B., Lewtas J., Mišková I., Rössner P., Cerná M., Mrácková G., Peterková K., Mumford J., Meyer S., Šrám R. Biomarker studies in Northern Bohernia. Environ. Health Perspect. 104(Suppl. 3):1996;591-597.
19. Bird A.W., Yu D.Y., Pray-Grant M.G., Qiu Q., Harmon K.E., Megee P.C., Grant P.A., Mitchell Smith M., Christman M.F. Acetylation of histone H4 by Esal is required for double-strand break repair. Nature. 419:2002;411-415.
20. Bonassi S., Abbondandolo A., Camurri L., Dal Prá A., De Ferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P., Sbrana I., Vecchio D., Puntoni R. Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet. 79:1995;133-135.
21. Bonassi S., Hagmar L., Strömberg U., Huici Montagud A., Tinnerberg H., Forni A., Heikkilä P., Wanders S., Wilhardt P., Hansteen I.-L., Knudsen L., Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res. 60:2000;1619-1625.
22. Brescia G., Celotti L., Clonfero E., Neumann H.G., Forni A., Foá V., Pisoni M., Ferri G.M., Assennato G. The influence of cytochrome P450 lAl and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers. Arch. Toxicol. 73:1999;431-439.
23. Brockmöller J., Gross D., Kerb R., Drakoulis N., Roots I. Correlation between transstilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class Mu gene detected by polymerase chain reaction. Biochem. Pharmacol. 43:1992;647-650.
24. Buschini A., De Palma G., Poli P., Martino A., Mozzoni P., Scotti E., Buzio L., Bergamaschi E., Mutti A. Genetic polymorphism of drug-metabolizing enzymes and styrene-induced DNA damage. Environ. Mol. Mutagen. 41:2003;243-252.
25. Butkiewicz D., Grzybowska E., Hemminki K., Øverbrø S., Haugen A., Motykiewicz G., Choraży M. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res. 415:1998;97-108.
26. Butkiewicz D., Cole K.J., Phillips D.H., Harris C.C., Choraży M. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct level. Eur. J. Cancer. 8:1999;315-323.
27. Butkiewicz D., Grzybowska E., Phillips D., Choraży M. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ. Mol. Mutag. 35:2000;99-105.
28. Cajas-Salazar N., Au W.W., Zwischenberger J.B., Sierra-Torres C.H., Salama S.A., Alpard S.K., Tyring S.K. Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk of lung cancer. Cancer Genet. Cytogenet. 145:2003;97-102.
29. Carrozza M.J., Utley R.T., Workman J.L., Côté J. The diverse functions of histone acetyltransferase complexes. Trends Genet. 19:2003;321-329.
30. Carere A., Andreoli C., Galati R., Leopardi P., Marcon F., Rosati M.V., Rossi S., Tomei F., Verdina A., Zijno A., Crebelli R. Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen. Mutat. Res. 518:2002;215-224.
31. Carstensen U., Alexandrie A.K., Högstedt B., Rannug A., Bratt I., Hagmar L. B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu). Mutat. Res. 289:1993;187-195.
32. Carstensen U., Hou S.M., Alexandrie A.K., Högstedt B., Tagesson C., Warholm M., Rannug A., Lambert B., Axmon A., Hagmar L. Influence of genetic polymorphisms of biotransformation enzymes on gene mutations, strand breaks of deoxyribonucleic acid, and micronuclei in mononuclear blood cells and urinary 8-hydroxyguanosine in potroom workers exposed to polyaromatic hydrocarbons. Scand. J. Work Environ. Health. 25:1999;351-360.
33. Cheng T.-J., Christiani D.C., Xu X., Wain J.C., Wiencke J.K., Kelsey K.T. Glutathione 5-transferase genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol. Biomarker Prev. 4:1995a;535-542.
34. Cheng T.-J., Christiani D.C., Wiencke J.K., Wain J.C., Xu X., Kelsey K.T. Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat. Res. 348:1995b;75-82.
35. Cheng T.-J., Christiani D.C., Xu X., Wain J.C., Wiencke J.K., Kelsey K.T. Increased micronucleus frequency in lymphocytes from smokers with lung cancer. Mutat. Res. 349:1996;43-50.
36. Cheng T.-J., Hwang S.-J., Kuo H.-W., Luo J.-C., Chang M.J.W. Exposure to epichiorohydrin and dimethylformamide, glutathione S-transferases and sister chromatid exchange frequencies in peripheral lymphocytes. Arch. Toxicol. 73:1999;282-287.
37. Conforti-Froes N., El-Zein R., Abdel-Rahman S.Z., Zwischenberger J.B., Au W.W. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. Mutat. Res. 379:1997;53-59.
38. Crott J.W., Mashiyama S.T., Ames B.N., Fenech M.F. Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. Carcinogenesis. 22:2001a;1019-1025.
39. Crott J.W., Mashiyama S.T., Ames B.N., Fenech M. The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol. Biomarkers Prev. 10:2001b;1089-1096.
40. Dallinga J.W., Pachen D.M.F.A., Wijnhoven S.W.P., Breedijk A., van't Veer L., Wigbout G., van Zandwijk N., Maas L.M., van Agen E., Kleinjans J.C.S., van Schooten F.-J. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes. Cancer Epidemiol. Biomarkers Prev. 7:1998;571-577.
41. D'Arce L.P.G., de Syllos Cólus I.M. Cytogenetic and molecular biomonitoring of agricultural workers exposed to pesticides in Brazil. Teratogen. Carcinogen. Mutagen. 20:2000;161-170.
42. De Palma G., Manini P., Mozzoni P., Andreoli R., Bergamaschi E., Cavazzini S., Franchini I., Mutti A. Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chem. Res. Toxicol. 14:2001;1393-1400.
43. Duell E.J., Wiencke J.K., Cheng T.-J., Varkonyii A., Zuo Z.F., Ashok T.D.S., Mark E.J., Wain J.C., Christiani D.C., Kelsey K.T. Polymorphisms in the DNA repair genes XRCCl and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 21:2000;965-971.
44. El-Zein R., Conforti-Froes N., Au W.W. Interactions between genetic predisposition and environmental toxicants for development of lung cancer. Environ. Mol. Mutag. 30:1997;196-204.
45. Engel L.S., Taioli E., Pfeiffer R., Garcia-Closas M., Marcus P.M., Lan Q., Boffetta P., Vineis P., Autrup H., Bell D.A., Branch R.A., Brockmöller R., Daly A.K., Heckbert S.R., Kalina I., Kang D., Katoh T., Lafliente A., Lin H.J., Ronikes M., Taylor J.A., Rothman N. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am. J. Epidemiol. 156:2002;95-109.
46. Falck G.C.-M., Hirvonen A., Scarpato R., Saarikoski S.T., Migliore L., Norppa H. Micronuclei in blood lymphocytes and genetic polymorphism for GSTM1, GSTT1 and NAT2 in pesticide-exposed greenhouse workers. Mutat. Res. 441:1999;225-237.
47. Fenech M. The advantages and disadvantages of the cytokinesis-block micronucleus method. Mutat. Res. 392:1997;11-18.
48. Fennell T.R., MacNeela J.P., Morris R.W., Watson M., Thompson C.L., Bell D.A. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigareffe smokers: effects of glutathione S4ransferase T1-null and M1-null genotypes. Cancer Epidemiol. Biomarkers Prev. 9:2000;705-712.
49. Firozi P., Bondy M.L., Sahin A.A., Chang P., Lukmanji F., Singletary E.S., Hassan M.M., Li D. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis. 23:2002;301-306.
50. Fustinoni S., Soleo L., Warholm M., Begemann P., Rannug A., Neumann H.G., Swenberg J.A., Vimercati L., Colombi A. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 11:2002;1082-1090.
51. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment. Cancer Epidemiol. Biomarkers Prev. 10:2001;1233-1237.
52. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autnip J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmöller J., Cascorbi I., Clapper M.L., Coutelle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh A.A., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le Marchand L., Lechner M.C., van Lieshout E.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Pari F.F., Pastorelli R., Persson I., Peters W.H., Rannug A., Rebbeck T., Risch A., Roelandt R., Romkes M., Ryberg J., Salagovic J., Schoket B., Seidegard J., Shields P.O., Sim E., Sinnet D., Strange R.C., Stücker I., Sugimura H., To-Figueras J., Vineis P., Yu M.C., Tajoli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10:2001;1239-1248.
53. Godschalk R.W.L., Dalinga J.W., Wikman H., Risch A., Kleinjans C.S., Bartsch H., Van Schooten F.-J. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1, GSTT1, NAT1 and NAT2. Pharmacogenetics. 11:2001;389-398.
54. Hagmar L., Brøgger A., Hansteen I.-L., Heim S., Högstedt B., Knudsen L., Lambert B., Linnainrnaa K., Mitelman F., Nordenson I., Reuterwall C., Salomaa S., Skeriving S., Sorsa M. Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Res. 54:1994;2919-2922.
55. Hagmar L., Bonassi S., Strömberg U., Brøgger A., Knudsen L., Norppa H., Reuterwall C., Forni A., Hansteen I.-L., Högstedt B., Huici Montagud A., Lambert B., Mitelman F., Nordenson I., Salomaa S., Skerfving S. Chromosomal aberrations in lymphocytes predict human cancer - a report from the Buropean Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 58:1998;4117-4121.
56. Hasan S., Hottiger M.G. Histone acetyl transferases: a role in DNA repair and DNA replication. J. Mol. Med. 80:2002;463-474.
57. Hasset C., Aicher L., Sidhu J.S., Omiecinski C.J. Human microsomal epoxide hydrolase: genetic polymorphism and flinctional expression in vitro of amino acid variants. Hum. Mol. Genet. 3:1994;421-428. and 1214.
58. Haufroid V., Buchet J.P., Gardinal S., Ghittori S., Imbriani M., Hirvonen A., Lison D. Importance of genetic polymorphisms of drug-metabolising enzymes for the interpretation of biomarkers of exposure to styrene. Biomarkers. 6:2001;236-249.
59. Haufroid V., Jakubowski M., Janasik B., Ligocka D., Buchet J.P., Bergamaschi E., Manini P., Mutti A., Ghittori S., Arand M., Hangen N., Oesch F., Hirvonen A., Lison D. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics. 12:2002;691-702.
60. Hayes R.B., Zhang L., Yin S., Swenberg J.A., Xi L., Wiencke J., Bechtold W.E., Rothman N., Haas R., O'Neill J.P.O., Zhang D., Wiemels J., Dosemeci M., Li G., Smith M.T. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis. 21:2000;55-62.
61. Hein D.W. Molecular genetics and flinction of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res. 506-507:2002;65-77.
62. Hirvonen, A., 1999. Polymorphic NATs and cancer predisposition, In: Ryder, W. (Ed.), Metabolic Polymorphisms and Susceptibility to Cancer. IARC Science Publication, vol. 148, pp. 251-270.
63. Hou S.-M., Fält S., Yang K., Nyberg F., Pershagen G., Hemminki K., Lambert B. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls. Cancer Epidemiol. Biomarkers Prev. 10:2001;133-140.
64. Hu Y., Oscarson M., Johansson I., Yue Q.Y., Dahl M.L., Tabone M., Arinco S., Albano E., Ingelman-Sundberg M. Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol. Pharmacol. 51:1997;370-376.
65. Hung R.J., Boffetta P., Brockmöller J., Butkiewicz D., Cascorbi I., Clapper M.L., Garte S., Haugen A., Hirvonen A., Anttila S., Kalina I., Le Marchand L., London S.J., Rannug A., Romkes M., Salagovic J., Schoket B., Gaspari L., Taloli E. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis. 24:2003;875-882.
66. Hukkanen J., Hakkola J., Anttila S., Piipari R., Kaijalainen A., Pelkonen G., Raunlo H. Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Mol. Carcinog. 20:1997;224-230.
67. Ichiba M., Hagmar L., Rannug A., Högstedt B., Alexandrie A.-K., Carstensen U., Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST in chimney sweeps. Carcinogenesis. 15:1994;1347-1352.
68. Johnson R.D., Jasin M. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. EMBO J. 19:2000;3398-3407.
69. Kalina I., Brezáni P., Gajdosova D., Binková B., Salagovic J., Habalova V., Nirackova G., Dobiás L., Šrám R. Cytogenetic monitoring in coke oven workers. Mutat. Res. 417:1998;9-17.
70. Karahalil B., Sardas S., Kocabas A.N., Alhayiroglu E., Karakaya A.B., Civelek E. Chromosomal aberrations under basal conditions and after treatment with X-ray in human lymphocytes as related to the GSTM1 genotype. Mutat. Res. 515:2002;135-140.
71. Kelsey K.T., Wiencke J.K., Ward J., Bechtold W., Fajen J. Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat. Res. 335:1995;267-273.
72. 0 exposures. Mutat. Res. 439:1999;13-23.
73. Knudsen L.B., Norppa H., Gamborg M.G., Nielsen P.S., Okkels H., Soll-Johanning H., Raffli E., Järventaus H., Autrup H. Chromosomal aberrations induced by urban air pollution in humans: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol. Biomarkers Prev. 8:1999;303-310.
74. Kulkarni M.S., Sherman F. NAT2, an essential gene encoding methionine N-acetyltransferase in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 269:1994;13141-13147.
75. Kure B., Thorsen M., Hansteen I.-L. Gene-exposure interaction in occupational and environmental epidemiology: results from an ongoing study. Norsk Epidemiol. 9:1999;39-46.
76. Laffon B., Pásaro E., Méndez J. Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene. Toxicology. 171:2002;175-186.
77. Laffon B., Perez-Cadahia B., Pásaro B., Méndez J. Effect of epoxide hydrolase and glutathione S-transferase genotypes on the induction of micronuclei and DNA damage by styrene-7,8-oxide in vitro. Mutat. Res. 536:2003a;49-59.
78. Laffon B., Perez-Cadahia B., Pásaro B., Méndez J. Individual sensitivity to DNA damage induced by styrene in vitro: influence of cytochrome P450, epoxide hydrolase and glutathione S-transferase genotypes. Toxicology. 186:2003b;131-141.
79. Landi S., Ponzanelli I., Hirvonen A., Norppa H., Barale R. Repeated analysis of sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes: effect of glutathione S-transferases T1 and M1 genotype. Mutat. Res. 351:1996;79-85.
80. Landi S., Norppa H., Frenzilli G., Cipollini G., Ponzanelli I., Barale R., Hirvonen A. Individual sensitivity to cytogenetics effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: effect of glutathione S-transferases M1, P1 and T1 genotypes. Pharmacogenetics. 8:1998;461-471.
81. Lei Y.-C., Hwang S.-J., Chang C.-C., Kuo H.-W., Luo J.-C., Chang M.J.W., Cheng T.-J. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat. Res. 519:2002;93-101.
82. Lee W.J., Brennan P., Boffetta P., London S.J., Benhamou S., Rannug A., To-Figueras J., Ingelman-Sundberg M., Shields P., Gaspari L., Tajoli B. Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review. Biomarkers. 7:2002;230-241.
83. Le Marchand L., Ouo C., Benhamou S., Bouchardy C., Cascorbi I., Clapper M.L., Garte S., Ingelman-Sundberg M., Kihara M., Rannug A., Rydberg D., Stücker I., Sugimura H., Taioli E. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control. 14:2003;339-346.
84. Leopardi P., Zijno A., Marcon F., Canti L., Carere A., Verdina A., Galati R., Tomei F., Baccolo T.P., Crebelli R. Analysis of micronuclei in peripheral blood lymphocytes of traffic wardens: effect of exposure, metabolic genotypes, and inhibition of excision repair in vitro by ARA-C. Environ. Mol. Mutag. 41:2003;126-130.
85. Liou S.H., Lung J.C., Chen Y.H., Yang T., Hsieh L.L., Chen C.J., Wu T.N. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res. 59:1999;1481-1484.
86. 1-DNA adducts and glycophorin A variant frequency. Cancer Res. 59:1999;2557-2561.
87. Lucero L., Pastor S., Suarez S., Durban R., Oómez C., Parrón T., Creus A., Marcos R. Cytogenetic biomonitoring of Spanish greenhouse workers exposed to pesticides: micronuclei analysis in peripheral blood lymphocytes and buccal epithelial cells. Mutat. Res. 464:2000;255-262.
88. 32P -DNA adducts in a sample of healthy subjects Carcinogenesis. 22:2001a;1437-1445.
89. Matullo G., Guarrera S., Carturan S., Peluso M., Malaveille C., Davico L., Piazza A., Vineis P. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer. 92:2001b;562-567.
90. Minchin R.F. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem. J. 307:1995;1-3.
91. m aldehyde dehydrogenase (ALDH2) polymorphism, alcohol-drinking behaviour, and chromosome alterations in peripheral lymphocytes. Environ. Health Perspect. 104(Suppl. 3):1996;563-567.
92. Motykiewicz G., Michaiska J., Pendzich J., Malusecka E., Sróżyk M., Kalinowska E., Butkiewitcz D., Mielżyńska D., Midro A., Santella R.M., Choraży M. A molecular epidemiology study in women from Upper Silesia, Poland. Toxicol. Lett. 96(97):1998;195-202.
93. Müller M., Krämer A., Angerer J., Hallier E. Ethylene oxide-protein adduct formation in humans: influence of glutathione-S- transferase polymorphisms. Int. Arch. Occup. Environ. Health. 71:1998;499-502.
94. Nielsen P.S., de Pater N., Okkels H., Autrup H. Environmental air pollution and DNA adducts in Copenhagen bus drivers - effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis. 17:1996;1021-1027.
95. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ. Health Perspect. 105(Suppl. 4):1997;829-835.
96. Norppa, H., 2000. Influence of genetic enzyme polymorphisms on cytogenetic biomarkers. In: Anderson, D., Karakaya, A.E., Srám, R.J. (Eds.), Human Monitoring after Environmental and Occupational Exposure to Chemical and Physical Agents. NATO Science Series, Series A: Life Sciences, vol. 313. 105 Press, Amsterdam, pp. 300-311.
97. Norppa H. Genetic polymorphisms and chromosome damage. Int. J. Hyg. Environ. Health. 204:2001;31-38.
98. Norppa H. Genetic susceptibility, biomarker responses, and cancer. Mutat. Res. 544:2003;339-348.
99. Norppa, H., 2004. Cytogenetic biomarkers. In: Mechanistic Considerations in the Molecular Epidemiology of Cancer. IARC Science Publication, vol. 157, in press.
100. Norppa H., Falck G.C.-M. What do human micronuclei contain? Mutagenesis. 18:2003;221-233.
101. Norppa, H., Hirvonen, A., 2000. Metabolic polymorphisms of importance in biomonitoring. In: Anderson, D., Karakaya, A.E., Srám, R.J. (Eds.), Human Monitoring after Environmental and Occupational Exposure to Chemical and Physical Agents. NATO Science Series, Series A: Life Sciences, vol. 313. 105 Press, Amsterdam, pp. 289-299.
102. Norppa H., Hirvonen A., Järventaus H., Uusküla M., Tasa G., Ojajärvi A., Sorsa M. Role of GSTT1 and OSTM1 genotypes in detennining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis. 16:1995;1261-1264.
103. Norppa H., Bemardini S., Wikman H., Järventaus H., Rosenberg C., Bolognesi C., Hirvonen A. Cytogenetic biomarkers in occupational exposure to dii socyanates: influence of genetic polymorphisms of metabolic enzymes. Environ. Mol. Mutag. 35(Suppl. 31):2000;45.
104. Norppa H., Lindholm C., Ojajärvi A., Salomaa S., Hirvonen A. Metabolic polymorphisms and frequency of chromosomal aberrations. Environ. Mol. Mutag. 37(Suppl. 32):2001;58.
105. Nyberg F., Hou S., Hemminki K., Lambert B., Pershagen G. Olutathione S-transferase 1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol. Biomark Prev. 7:1998;875-883.
106. Ollikainen T., Hirvonen A., Norppa H. Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes. Environ. Mol. Mutagen. 31:1998;311-315.
107. Ouspenski I.I., Elledge S.J., Brinkley B.R. New yeast genes important for chromosome integrity and segregation identified by dosage effects on genome stability. Nucl. Acid Res. 27:1999;3001-3008.
108. Palli D., Russo A., Masala G., Saieva C., Guarrera S., Carturan S., Munnia A., Matullo G., Peluso M. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer. 94:2001;121-127.
109. Pastorelli R., Cerri A., Mexxetti M., Consonni E., Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int. J. Cancer. 100:2002;9-13.
110. Pavanello S., Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat. Res. 463:2000;285-308.
111. Pavanello S., Gabbanl G., Mastrangelo G., Bruggnone F., Maccacaro G., Clonfero E. Influence of 0STM1 genotypes on anti-BPDE-DNA adduct levels in mononuclear white blood cells of humans exposed to PAH. Int. Arch. Environ. Health. 72:1999;238-246.
112. Pelin K., Hirvonen A., Norppa H. Influence of erytlirocyte glutathione S-transferases T1 on sister chromatid exchanges induced by diepoxybutane in cultured human lymphocytes. Mutagenesis. 11:1996;213-215.
113. Peluso M., Airoldi L., Armelle M., Martone T., Coda R., Malveille C., Giacomelli G., Terrone C., Casetta G., Vineis P. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case control study. Cancer Epidemiol. Biomarkers Prev. 7:1998;341-346.
114. Peluso M., Airoldi L., Magagnotti C., Fiorini L., Munnia A., Hautefeuille A., Malveille C., Vineis P. White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis. 21:2000;183-187.
115. Pemble S., Schroeder K.R.T., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., Taylor J.B. Human glutathione S-transferase theta (GSTT1): c-DNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300:1994;271-276.
116. Pitarque M., Vaglenov A., Nosko M., Paviova S., Petkova V., Hirvonen A., Creus A., Norppa H., Marcos R. Sister chromatid exchanges and micronuclei in peripheral lymphocytes of solvent-exposed shoe workers. Environ. Health Perspect. 110:2002;399-404.
117. Pluth J.M., Nelson D.O., Ramsey M.J., Tucker J.D. The relationship between genotype and chromosome aberrations frequencies in a normal adult population. Pharmacogenetics. 10:2000a;311-319.
118. Pluth J.M., Ramsey M., Tucker J.D. Role of maternal exposures and newborn genotypes on newborn chromosome aberration frequencies. Mutat. Res. 465:2000b;101-111.
119. Qin S., Parthum M.R. Histone h3 and the histone acetyltransferase hatip contribute to DNA double-strand repair. Mol. Cell Biol. 22:2002;8353-8365.
120. Raucy J.L., Ingelman-Sundberg M., Carpenter S., Rannug A., Rane A., Franklin M., Rorrikes M. Drug metabolizing enzymes in lymphocytes. J. Biochem. Mol. Toxicol. 13:1999;223-226.
121. Rojas M., Alexandrov K., Cascorbi I., Brockmöller J., Likhachev A., Pozharisski K., Bouvier G., Auburtin G., Mayer L., Roots I., Bartsch H. High benzo(a)pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI GSTM1*0/*0 genotypes. Pharmacogenetics. 8:1998;109-118.
122. Rojas M., Cascorbi I., Alexandrov K., Kriek E., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., Bartsch H. Modulation of benzo(a)pyrene diolepoxide-DNA adduct levels in human blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis. 21:2000;35-41.
123. Ruttan C.C., Glickman B.W. Coding variants in human double-strand break DNA repair genes. Mutat. Res. 509:2002;175-200.
124. Ryberg D., Hewer A., Phillips D.H., Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 54:1994;5801-5803.
125. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Øgreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
126. Salama S.A., Abdel-Rahman S.Z., Sierra-Torres C.H., Hamada E.A., Au W.W. Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics. 9:1999;735-743.
127. Salama S.A., Sierra-Torres C.H., Oh H.Y., Hamada F.A., Au W.W. Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ. Mol. Mutagen. 37:2001;17-26.
128. Sasiadek M., Hirvonen A., Noga L., Paprocka-Borowicz M., Norppa H. Glutathione S-transferase M1 genotype influences sister chromatid exchange induction but not adaptive response in human lymphocytes treated with 1,2-epoxy-3-butene. Mutat. Res. 439:1999;207-212.
129. Scarpato R., Migliore L., Hirvonen A., Falck G., Norppa H. Cytogenetic monitoring of occupational exposure to pesticides: characterization of GSTM1, GSTT1 and NAT2 genotypes. Environ. Mol. Mutag. 27:1996;263-269.
130. Scarpato R., Hirvonen A., Migliore L., Falck G., Norppa H. Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat. Res. 389:1997;227-235.
131. Schlade-Bartusiak K., Sasiadek M., Kozlowska J. The influence of GSTM1 and GSTT1 genotypes on the induction of sister chromatid exchanges and chromosome aberrations by 1,2:3,4-diepoxybutane. Mutat. Res. 465:2000;69-75.
132. Schröder K.R., Wiebel F.A., Reich S., Dannappel D., Bolt H.M., Hallier E. Glutathione-S-transferase (GST) theta polymorphism influences background SCE rate. Arch. Toxicol. 69:1995;505-507.
133. Seiler N., Knodgen B., Bartholeyns J. Polyamlne metabolism and polyamine excretion in normal and tumour bearing rodents. Anticancer Res. 5:1985;371-377.
134. Shen M.R., Jones I.M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58:1998;604-608.
135. Shield A.J., Sanderson B.J. Role of glutathione S-transferase mu (GSTM1) in styrene-78-oxide toxicity and mutagenicity. Environ. Mol. Mutagen. 37:2001;285-289.
136. Shields P.O., Bowman B.D., Harrington A.M., Doan V.T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in lung and cancer susceptibility genes. Cancer Res. 53:1993;3486-3492.
137. Smerhovsky Z., Landa K., Rössner P., Brabec M., Zudova Z., Hola N., Pokoma Z., Mareckova J., Hurychova D. Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. Environ. Health Perspect. 109:2001;41-45.
138. Smerhovsky Z., Landa K., Rössner P., Juzova D., Brabec M., Zudova Z., Hola N., Zarska H., Nevsimalova E. Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations. Mutat. Res. 514:2002;165-176.
139. Soni M., Madurantakan M., Krishnaswamy K. Glutathione S-transferase Mu (GST Mu) deficiency and DNA adducts in lymphocytes of smokers. Toxicology. 126:1998;155-162.
140. Sonoda E., Sasaki M., Morrison C., Yamaguchi-Iwai Y., Takata M., Takeda S. Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol. Cell. Biol. 19:1999;5166-5169.
141. Sorsa M., Osterman-Golkar S., Peltonen K., Saarikoski S.T., Šrám R. Assessment of exposure to butadiene in the process industry. Toxicology. 113:1996;77-83.
142. Šrám R., Rössner P., Peltonen K., Podrazilová K., Mrackova G., Demopoulos N.A., Stephanou G., Viachodimitropoulos D., Darroudi F., Tates A.D. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1,3-butadiene-exposed workers. Mutat. Res. 419:1998;145-154.
143. Šrám R., Birkova B., Rössner P., Rubes J., Topinka J., Dejmek J. Adverse reproductive outcomes from exposure to environmental mutagens. Mutat. Res. 428:1999;203-215.
144. Strange R.C., Fryer A.A. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci. Publ. 148:1999;231-249.
145. Strange R.C., Jones P.W., Fryer A.A. Glutathione S-transferase: genetics and role in toxicology. Toxicol. Lett. 112-113:2000;357-363.
146. Taioli E., Gaspari L., Benhamou S., Boffetta P., Brockmöller J., Butkiewicz D., Cascorbi I., Clapper M.L., Doizan V., Haugen A., Hirvonen A., Husgafvel-Pursiainen K., Kalina I., Kremers P., Le Marchand L., London S., Rannug A., Romkes M., Schoket B., Seidegard J., Strange R.C., Stücker I., To-Figueras J., Garte S. Polymorphisms in CYP1A1, GSTM1 GSTT1 and lung cancer below the age of 45 years. Int. J. Bpidemiol. 32:2003;60-63.
147. Tang D.L., Rundle A., Warburton D., Santella R.M., Tsai W.-Y., Chiamprasert S., Hsu Y.Z., Perera F.P. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis. 19:1998;1949-1953.
148. Thier R., Lewalter J., Kempkes M., Selinski S., Bruning T., Bolt H. Haemoglobin adducts of acrylonitrile and ethylene oxide in acrylonitrile workers, dependent on polymorphisms of the glutathione transferases GSTT1 and GSTM1. Arch. Toxicol. 73:1999;197-202.
149. Thier R., Balkenhol H., Lewalter J., Selinski S., Dommermuth A., Bolt H. Influence of polymorphisms of the human glutathione transferases and cytochrome P450 2E1 enzyme on the metabolism and toxicity of ethylene oxide and acrylonitrile. Mutat. Res. 482:2001;41-46.
150. Tuimala J., Szekely G., Gundy S., Hirvonen A., Norppa H. Genetic polymorphisms of DNA repair and xenobiotic metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis. 23:2002;1003-1008.
151. Uusküla M., Järventaus H., Hirvonen A., Sorsa M., Norppa H. Influence of GSTM1 genotype on sister chromatid exchanges induced by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis. 16:1995;947-950.
152. van Delf J.H.M., Steenwinkel M.-J.S.T., van Asten J.G., de Vogel N., Bruijntjes T.C.D.M., Schouten T., Cramers P., Maas L., van Herwijnen M.H., van Schooten F.-J., Hopmans P.M.J. Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1. Ann. Occup. Hyg. 45:2001;395-408.
153. van Poppel G., de Vogel N., van Bladeren P.J., Kok F.J. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme. Carcinogenesis. 13:1992;303-305.
154. van Poppel G., Verhagen H., van't Veer P., van Blanderen P.J. Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase μ Cancer Epidemiol. Bioamarkers Prev. 2:1993;441-447.
155. Viezzer C., Norppa H., Clonfero E., Gabbani G., Mastrangelo G., Hirvonen A., Celotti L. Influence of GSTM1, GSTT1, GSTP1 and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers. Mutat. Res. 431:1999;259-269.
156. Vineis P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology. 181-182:2002;457-462.
157. Vineis P., Bartsch H., Caporaso N., Harrington A.M., Kadlubar F.K., Landi M.T., Malaveille C., Shields P.O., Skipper P., Talaska G., Tannenbaum S.R. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature. 369:1994;154-156.
158. Vineis P., Veglia F., Benhamou S., Butkiewicz D., Cascorbi I., Clapper M.L., Dolzan V., Haugen A., Hirvonen A., Ingelman-Sundberg M., Kihara M., Kiyohara C., Kremers P., Le Marchand L., Ohshima S., Pastorelli R., Rannug A., Romkes M., Schoket B., Shields P., Strange R.C., Stücker I., Sugimura H., Garte S., Gaspari L., Taioli B. CYP1A1 T3801C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int. J. Cancer. 104:2003;650-657.
159. Vlachodimitropoulos D., Norppa H., Autio K., Catalan J., Hirvonen A., Tasa G., Uusküla M., Demopoulos N.A., Sorsa M. GSTT1-dependent induction of centromere-negative and -positive micronuclei by diepoxybutane in cultured human lymphocytes. Mutagenesis. 12:1997;397-403.
160. Vodička P., Soucek P., Tates A.D., Dusinska M., Sarmanova J., Zameenikova M., Vodickova L., Koskinen M., de Zwart F.A., Natarajan A.T., Hemminki K. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat. Res. 482:2001;89-103.
161. Vodička P., Kumar R., Soucek P., Haufroid V., Stetina R., Dusinska M., Kuricova M., Zamenikova M., Buchanova J., Norppa H., Vodickova L., Matousu Z., Hemminki K. Genetic polymorphisms of DNA repair and biotransformation genes and possible links with chromosomal aberrations and single-strand breaks. Toxicol. Lett. 144(Suppl. 1):2003;s154.
162. Vodička, P., Kumar, R., Stetina, R., Sanyal, S., Soucek, P., Haufroid, V., Dusinska, M., Kuricova, M., Zamecnikova, M., Musak, L., Buchanova, J., Norppa, H., Hirvonen, A., Vodickova, L., Naccarati, A., Matousu, Z., Hemminki, K., 2004. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal abberations and single-strand breaks in DNA. Carcinogenesis, in press.
163. Warholm M., Rannug A., Fustinoni S., Begemann P., Soleo L., Barale R., Järventaus H., Norppa H. Influence of metabolic genotypes on chromosome aberrations in butadiene exposed workers. Toxicologist. 72(S1):2003;98.
164. Wenker M.A.M., Kezic S., Monster A.C., de Wolff F.A. Metabolism of styrene-7,8-oxide in human liver in vitro: interindividual variation and stereochemistry. Toxicol. Appl. Pharmacol. 169:2000;52-58.
165. Wiencke J.K., Kelsey K.T., Lamela R.A., Toscano W.A. Jr. Human glutathione S-transferase as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res. 50:1990;1585-1590.
166. Wiencke J.K., Christiani D.C., Kelsey K.T. Bimodal distribution of sensitivity to SCE induction by diepoxybutane in human lymphocytes. I. Correlation with chromosomal aberrations. Mutat. Res. 248:1991;17-26.
167. Wiencke J.K., Pemble S., Ketterer B., Kelsey K.T. Gene deletion of glutathione S-transferase θ: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomarker Prev. 4:1995;253-259.
168. Wong R.-H., Wang J.-D., Hsieh L.-L., Du C.-L., Cheng T.-J. Effect on sister chromatid exchange frequency of acetaldehyde dehydrogenase 2 genotype and smoking in vinyl chloride workers. Mutat. Res. 420:1998;99-107.
169. Wong R.-H., Wang J.-D., Hsieh L.-L., Cheng T.-J. XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency alterations amongst vinyl chloride monomer-exposed polyvinyl chloride workers. Arch. Toxicol. 77:2003;433-440.
170. Wu F.-Y., Tsai F.-J., Kuo H.-W., Tsai C.-H., Wu W.-Y., Wang R.-Y., Lai J.-S. Cytogenetic study of workers exposed to chromium compounds. Mutat. Res. 464:2000;289-296.
171. Xu X., Wiencke J.K., Nin T., Wang M., Watanabe H., Kelsey K.T., Christiani D. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am. J. Ind. Med. 33:1998;157-163.
172. Yong L.C., Schulte P.A., Wiencke J.K., Boeniger M.F., Connally L.B., Walker J.T., Whelan E.A., Ward E.M. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S-transferase T1 and M1 genotypes. Cancer Epidemiol. Biomarkers Prev. 10:2001;539-550.
173. Zhao C., Vodička P., Šrám R.J., Hemminki K. DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen. 37:2001;226-230.
174. Zijno A., Andreoli C., Leopardi P., Marcon F., Rossi S., Caiola S., Verdina A., Galati R., Cafolla A., Crebelli R. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis. 24:2003;1097-1103.